1985
DOI: 10.1016/0006-291x(85)90458-9
|View full text |Cite
|
Sign up to set email alerts
|

1-Aminooxy-3-aminopropane, a new and potent inhibitor of polyamine biosynthesis that inhibits ornithine decarboxylase, adenosylmethionine decarboxylase and spermidine synthase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
16
0

Year Published

1987
1987
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(16 citation statements)
references
References 34 publications
0
16
0
Order By: Relevance
“…However, since mice infected with spermidine synthase mutants remained healthy throughout the course of the experiment, spermidine synthase may be a more useful anticryptococcal, and perhaps antifungal, drug target. At least four spermidine synthase inhibitors have been developed (2,20,22,34), at least one of which (cyclohexylamine) is known to inhibit C. neoformans growth (36). The transcription of S. cerevisiae LYS9 is regulated in response to lysine levels.…”
Section: Discussionmentioning
confidence: 99%
“…However, since mice infected with spermidine synthase mutants remained healthy throughout the course of the experiment, spermidine synthase may be a more useful anticryptococcal, and perhaps antifungal, drug target. At least four spermidine synthase inhibitors have been developed (2,20,22,34), at least one of which (cyclohexylamine) is known to inhibit C. neoformans growth (36). The transcription of S. cerevisiae LYS9 is regulated in response to lysine levels.…”
Section: Discussionmentioning
confidence: 99%
“…Since this parasite enzyme has a lower turnover rate, when compared to mammalian homologs [42,66], treatment of experimental leishmaniasis with ODC inhibitors, such as D, L-α-difluoromethylornithine (DFMO) [67] and 3-aminooxy-1-aminopropane (APA) [68][69][70], is an effective measure for controlling parasitic infection [42,71]. In addition to the enzymes in Larginine metabolic pathways, the L-arginine transporter may serve as a potential target for antileishmania drugs.…”
Section: Targeting L-arginine Metabolic Pathways As a Therapeutic Appmentioning
confidence: 99%
“…The new inhibitors of ODC are related to 3-aminooxy-1-aminopropane (APA) (15,17,18,24,34), and those of AdoMetDC are derivatives of bis(guanylhydrazones) (29,30,35,36) (Fig. 1).…”
mentioning
confidence: 99%